Please assess the completion status of the following clinical trial:

Trial Title: Cortisone Injection vs Trigger Point Dry Needling Fin the Treatment of Greater Trochanter Pain Syndrome: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18+ years old~* lateral hip pain (anywhere from iliac crest to mid ITB)~* active email account~Exclusion Criteria:~* low back pain associated with the hip pain~* motor and/or sensory impairment consistent with radiculopathy~* active infection/malignancy of the hip~* connective tissue disease~* pregnancy~* non-English speaking

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cortisone Injection (Type: ACTIVE_COMPARATOR): Fifty patients with GTPS will be randomized into a CI or TDN group. Treatment will be carried out at the 1st visit following consent according to SOC. Treatment will be administered according to standard of care for up to 6 weeks.
- Trigger Point Dry Needling (Type: ACTIVE_COMPARATOR): Fifty patients with GTPS will be randomized into a CI or TDN group. Treatment will be carried out at the 1st visit following consent according to SOC. Treatment will be administered according to standard of care for up to 6 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).